Analysis of Jak2 signaling reveals resistance of mouse embryonic hematopoietic stem cells to myeloproliferative disease mutation. (2016)
Attributed to:
Wellcome Trust MRC Cambridge Stem Cell Institute
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood-2015-08-664631
PubMed Identifier: 26864339
Publication URI: http://europepmc.org/abstract/MED/26864339
Type: Journal Article/Review
Volume: 127
Parent Publication: Blood
Issue: 19
ISSN: 0006-4971